CA1082202A - Cyano acetic acid anilide derivatives, process for their manufacture and compositions containing these compounds - Google Patents

Cyano acetic acid anilide derivatives, process for their manufacture and compositions containing these compounds

Info

Publication number
CA1082202A
CA1082202A CA254,136A CA254136A CA1082202A CA 1082202 A CA1082202 A CA 1082202A CA 254136 A CA254136 A CA 254136A CA 1082202 A CA1082202 A CA 1082202A
Authority
CA
Canada
Prior art keywords
carbon atoms
anilide
formula
acid
represent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA254,136A
Other languages
English (en)
French (fr)
Inventor
Hartmut Ertel
Gunther Heubach
Erhard Wolf
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Application granted granted Critical
Publication of CA1082202A publication Critical patent/CA1082202A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/66—Nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA254,136A 1975-06-05 1976-06-04 Cyano acetic acid anilide derivatives, process for their manufacture and compositions containing these compounds Expired CA1082202A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2524929A DE2524929C3 (de) 1975-06-05 1975-06-05 2-Hydroxyäthylidencyanessigsäureanilide, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Mittel
DEP2524929.0 1975-06-05

Publications (1)

Publication Number Publication Date
CA1082202A true CA1082202A (en) 1980-07-22

Family

ID=5948272

Family Applications (1)

Application Number Title Priority Date Filing Date
CA254,136A Expired CA1082202A (en) 1975-06-05 1976-06-04 Cyano acetic acid anilide derivatives, process for their manufacture and compositions containing these compounds

Country Status (15)

Country Link
US (1) US4061767A (OSRAM)
JP (1) JPS6032620B2 (OSRAM)
AT (1) AT343641B (OSRAM)
BE (1) BE842688A (OSRAM)
CA (1) CA1082202A (OSRAM)
CH (1) CH627444A5 (OSRAM)
DE (1) DE2524929C3 (OSRAM)
DK (1) DK157078C (OSRAM)
FR (1) FR2313031A1 (OSRAM)
GB (1) GB1555555A (OSRAM)
IE (1) IE43004B1 (OSRAM)
IT (1) IT1063593B (OSRAM)
LU (1) LU75075A1 (OSRAM)
MX (1) MX3170E (OSRAM)
NL (2) NL186239C (OSRAM)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55500866A (OSRAM) * 1978-11-03 1980-10-30
US4173650A (en) * 1978-11-03 1979-11-06 American Cyanamid Company Cis-2-benzoyl-3-hydroxy-2-alkenonitriles as anti-inflammatory agents
US4181677A (en) * 1978-12-13 1980-01-01 American Cyanamid Company 2-Benzoyl-3-alkoxy-2-alkenonitriles
US4259256A (en) * 1978-12-13 1981-03-31 American Cyanamid Company 2-Benzoyl-3-dimethylamino-2-alkenonitriles
US4256759A (en) * 1979-06-11 1981-03-17 Ciba-Geigy Corporation Alphacarbamoyl-pyrrolpropionitriles
EP0143142A3 (de) * 1979-06-11 1985-07-17 Ciba-Geigy Ag Alphacarbamoyl-pyrrolpropionitrile, Verfahren zu ihrer Herstellung, pharmazeutische Präparate enthaltend diese Verbindungen, sowie ihre therapeutische Verwendung
US4277420A (en) * 1979-09-24 1981-07-07 Monsanto Company Ephedrine and pseudoephedrine precursors
US4254048A (en) * 1979-12-17 1981-03-03 American Cyanamid Company Substituted phenyl alkylidene acetoacetonitriles
US4254047A (en) * 1979-12-17 1981-03-03 American Cyanamid Company Substituted phenyl-2-cyano-2-thioalkenoic acid esters
US4254049A (en) * 1979-12-17 1981-03-03 American Cyanamid Company Substituted phenyl-2-cyano-2-alkenoic acid esters
US4435407A (en) 1982-01-07 1984-03-06 Ciba-Geigy Corporation Certain substituted β-oxo-α-carbamoylpyrrolepropionitriles
US4644010A (en) * 1982-09-28 1987-02-17 Ciba-Geigy Corporation Certain β-oxo-α-carbamoylpyrrolepropionitriles
DE3247454A1 (de) * 1982-12-22 1984-06-28 Laboratorios Bago S.A., Buenos Aires Substituierte 3-phenyl-5-methyl-isoxazol-4-carboxy-anilide, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
US5268382A (en) * 1985-09-27 1993-12-07 Hoechst Aktiengesellschaft Medicaments to combat autoimmune diseases, in particular systemic lupus erythematosus
DE3534440A1 (de) * 1985-09-27 1987-04-02 Hoechst Ag Arzneimittel gegen chronische graft-versus-host-krankheiten sowie gegen autoimmunerkrankungen, insbesondere systemischen lupus erythematodes
GB8619433D0 (en) * 1986-08-08 1986-09-17 Lilly Industries Ltd Pharmaceutical compounds
GB8619432D0 (en) * 1986-08-08 1986-09-17 Lilly Industries Ltd Pharmaceutical compounds
US4888357A (en) * 1988-01-26 1989-12-19 Bristol-Myers Company Antiarthritic β-cycloalkyl-β-oxopropionitriles
US4975462A (en) * 1988-07-29 1990-12-04 Bristol-Myers Company Antiarthritic α-arylcarbamoyl cyanoacetic acid derivatives
DD297328A5 (de) 1989-08-18 1992-01-09 �������@���������k���Kk�� 5-methyl-isoxalol-4-carbonsaeureanilide und 2 hydroxyethyliden-cyanoessigsaeureanilide zur behandlung von augenerkrankungen
US5583150A (en) * 1989-08-18 1996-12-10 Alcon Laboratories, Inc. 5-methyl-isoxazole-4-carboxylic acid anilides and 2-hydroxyethylidene-cyano acetic anilides for the treatment of ocular diseases
US5034410A (en) * 1989-10-11 1991-07-23 Syntex (U.S.A.) Inc. Anthelmintically active benzenepropanamide derivatives
HU222234B1 (hu) * 1990-05-18 2003-05-28 Aventis Pharma Deutschland Gmbh. Eljárás izoxazol-4-karbonsav-amidok és hidroxi-alkilidén-cián-ecetsav-amidok, a vegyületeket tartalmazó gyógyászati készítmények és az ismert vegyületeket tartalmazó rákellenes hatású gyógyszerkészítmények előállítására
ZA913762B (en) 1990-05-18 1992-01-29 Hoechst Ag Isoxazole-4-carboxamides and hydroxyalkylidenecyanoacetamides,pharmaceuticals containing these compounds and their use
CA2058185A1 (en) * 1990-12-24 1992-06-25 Manfred Schudok Process for the acylation of alcohols with immobilized enzymes
DE4127737A1 (de) 1991-08-22 1993-02-25 Hoechst Ag Arzneimittel zur behandlung von abstossungsreaktionen bei organverpflanzungen
US6133301A (en) * 1991-08-22 2000-10-17 Aventis Pharma Deutschland Gmbh Pharmaceuticals for the treatment of rejection reactions in organ transplantations
IL102790A (en) * 1991-09-17 1996-01-31 Roussel Uclaf 3-Cycloalkyl-prop-2- enamide derivatives
NZ244814A (en) * 1991-10-23 1994-06-27 Hoechst Ag N-phenyl-2-cyano-3-hydroxycrotonamide derivatives and pharmaceutical compositions
GB9200275D0 (en) * 1992-01-08 1992-02-26 Roussel Lab Ltd Chemical compounds
GB9209330D0 (en) * 1992-04-30 1992-06-17 Roussel Lab Ltd Chemical compounds
GB9300083D0 (en) 1993-01-05 1993-03-03 Roussel Lab Ltd Chemical compounds
TW314467B (OSRAM) * 1993-03-31 1997-09-01 Hoechst Ag
AU6852594A (en) * 1993-06-03 1995-01-03 Therapeutic Antibodies Inc. Production of antibody fragments
GB9313365D0 (en) * 1993-06-29 1993-08-11 Roussel Lab Ltd Chemical compounds
GB9322781D0 (en) * 1993-11-04 1993-12-22 Roussel Lab Ltd Aromatic amides
LT3589B (en) 1993-11-30 1995-12-27 Hoechst Ag Using of known combination for treatment of rejection reaction by transplantation of organs
US5700823A (en) * 1994-01-07 1997-12-23 Sugen, Inc. Treatment of platelet derived growth factor related disorders such as cancers
US5519042A (en) * 1994-01-13 1996-05-21 Hoechst Aktiengesellschaft Method of treating hyperproliferative vascular disease
US6331555B1 (en) 1995-06-01 2001-12-18 University Of California Treatment of platelet derived growth factor related disorders such as cancers
DE19539638A1 (de) * 1995-10-25 1997-04-30 Hoechst Ag Die Verwendung von Isoxazol- und Crotonsäureamidderivaten zur Behandlung von Krebserkrankungen
DE19547648A1 (de) * 1995-12-20 1997-06-26 Hoechst Ag Zubereitung, enthaltend High Density Lipoproteine und Crotonsäureamidderivate
US5856330A (en) * 1996-07-31 1999-01-05 Hoechst Aktiengesellschaft Use of xanthine derivatives for the inhibition of dephosphorylation of cofilin
US5981536A (en) * 1996-07-31 1999-11-09 Hoechst Aktiengesellschaft Use of xanthine derivatives for the modulation of apoptosis
US6011051A (en) * 1996-07-31 2000-01-04 Hoechst Aktiengesellschaft Use of isoxazole and crotonamide derivatives for the modulation of apoptosis
US6316479B1 (en) 1997-05-19 2001-11-13 Sugen, Inc. Isoxazole-4-carboxamide compounds active against protein tryosine kinase related disorders
PT903345E (pt) 1997-08-08 2001-01-31 Aventis Pharma Gmbh Forma cristalina de n-(4-trifluorometilfenil)-5-metil-isoxazolo-4-carboxamida
US6355678B1 (en) * 1998-06-29 2002-03-12 Parker Hughes Institute Inhibitors of the EGF-receptor tyrosine kinase and methods for their use
US20050255071A1 (en) * 1998-12-10 2005-11-17 Aventis Pharma Deutschland Gmbh Preparation having improved therapeutic breadth comprising nucleotide synthesis inhibitors
GB0123571D0 (en) * 2001-04-05 2001-11-21 Aventis Pharm Prod Inc Use of (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide for treating multiple sclerosis
DE10132308A1 (de) * 2001-07-06 2003-01-30 Aventis Behring Gmbh Kombinationspräparat zur Therapie von immunologischen Erkrankungen
WO2003006424A1 (en) 2001-07-10 2003-01-23 4Sc Ag Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
US20050158371A1 (en) * 2002-02-12 2005-07-21 Sumitomo Pharmaceuticals Co., Ltd. Novel external agent
BR0317687A (pt) 2002-12-23 2005-11-22 4Sc Ag Compostos aromáticos como agentes antiinflamatórios, imunomoduladores e antiproliferativos
UA108760C2 (uk) 2010-07-01 2015-06-10 Кальцієві солі сполуки як протизапальні, імуномодулюючі та антипроліферативні засоби
TN2016000197A1 (en) 2013-11-22 2017-10-06 Genzyme Corp Novel methods for treating neurodegenerative diseases.
US10526279B2 (en) * 2015-06-17 2020-01-07 Biocon Limited Process for the preparation of teriflunomide
HUE067375T2 (hu) 2018-03-16 2024-10-28 Immunic Ag Új kalciumsó polimorfok gyulladásellenes, immunmodulátor és proliferáció elleni szerekként
US11376232B2 (en) 2020-04-21 2022-07-05 Immunic Ag Vidofludimus for use in the treatment or prevention of viral diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2288863A (en) * 1940-02-27 1942-07-07 Hoffmann La Roche Process for the manufacture of substituted amides of 3,5-dimethylisoxazole-4-carboxylic acid
BE506549A (OSRAM) * 1950-10-19

Also Published As

Publication number Publication date
BE842688A (fr) 1976-12-08
DK157078B (da) 1989-11-06
IE43004L (en) 1976-12-05
GB1555555A (en) 1979-11-14
JPS527929A (en) 1977-01-21
IE43004B1 (en) 1980-12-03
US4061767A (en) 1977-12-06
ATA413576A (de) 1977-10-15
JPS6032620B2 (ja) 1985-07-29
DK248476A (da) 1976-12-06
MX3170E (es) 1980-06-05
FR2313031A1 (fr) 1976-12-31
DE2524929C3 (de) 1980-10-09
CH627444A5 (de) 1982-01-15
DK157078C (da) 1990-04-09
LU75075A1 (OSRAM) 1977-03-07
FR2313031B1 (OSRAM) 1979-10-12
NL186239B (nl)
AT343641B (de) 1978-06-12
NL7605845A (en) 1976-12-07
DE2524929A1 (de) 1976-12-16
DE2524929B2 (de) 1980-01-31
IT1063593B (it) 1985-02-11
NL186239C (nl) 1990-10-16

Similar Documents

Publication Publication Date Title
CA1082202A (en) Cyano acetic acid anilide derivatives, process for their manufacture and compositions containing these compounds
CA1076584A (en) Isoxazole derivatives, process for their manufacture and compositions containing these compounds
EP0116948B1 (en) (2-oxo-1,2,3,5-tetrahydroimidazo-(2,1-b)quinazolinyl)-oxyalkyl-amides
EP0310370A1 (en) 2-aryl substituted heterocyclic compounds as antiallgeric and anti-inflammatory agents
Su et al. Strontium (II) triflate catalysed condensation of β-naphthol, aldehyde and urea or amides: a facile synthesis of amidoalkyl naphthols
HU221007B1 (hu) Fenil-cikloalkil-származékok és e vegyületeket hatóanyagként tartalmazó gyógyszerkészítmények, valamint eljárás előállításukra
NO128653B (OSRAM)
GB2123814A (en) Novel intermediates
US4797492A (en) Polyfluoroalkylisoxazolylamines
US4235928A (en) Substituted cyanamides and their use as fungicides
Barros et al. Hydroxamic acids designed as inhibitors of urease
US4085114A (en) 1,2-Benzoisoxazole derivatives and the production thereof
Shin et al. Convenient synthesis of fragment E of antibiotic, nosiheptide
US4282223A (en) Isoquinoline derivatives, processes for their manufacture and their use for the manufacture of medicaments
US4025528A (en) Thiazole derivatives of benzoic and phenylalkanoic acids
CA1072087A (en) Amides as ovulation inhibitors
DE2524959A1 (de) Neue isoxazolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende mittel
Kees et al. Synthesis and antiallergic activity of a novel series of 5-lipoxygenase inhibitors
US3944581A (en) 5-Substituted-2,4-diphenylpyrimidines
Veeraswamy et al. Synthesis of novel 5-substituted isoxazole-3-carboxamide derivatives and cytotoxicity studies on lung cancer cell line
US4767767A (en) 2-pyrrolidinylethyl-2-(7-trifluoromethyl-4-quinolyl-aminobenzoate having analgesic, antipyretic and anti-inflammatory activities
US4025537A (en) Preparation of 3-carboalkoxy or 3-alkanoyl furans
US4213905A (en) Preparation of 5-aroyl-1-loweralkylpyrrole-2-acetic acid salts
US4128550A (en) 1-Methyl-4-piperidyl 5-phenyl-2-furoates
US2855429A (en) (2-nitroalkenyl) phenoxyalkanoates and process

Legal Events

Date Code Title Description
MKEX Expiry